Use this form to give us your feedback or report any problems you experienced finding information on our Website.
* Indicates Required Fields
Thank you for providing feedback.
| Holding | Sector | Assets (%) |
|---|---|---|
| Citigroup, Inc. | Financials | 2.7 |
| Verizon Communications, Inc. | Telecommunication Services | 2.6 |
| JPMorgan Chase & Co. | Financials | 2.6 |
| AT&T, Inc. | Telecommunication Services | 2.3 |
| Actavis, Inc. | Health Care | 2.1 |
| Exxon Mobil Corp. | Energy | 2.0 |
| Capital One Financial Corp. | Financials | 1.9 |
| Express Scripts Holding Co. | Health Care | 1.8 |
| Thermo Fisher Scientific, Inc. | Health Care | 1.7 |
| Valero Energy Corp. | Energy | 1.7 |
| % of Total Assets | 21.4 |
| Sector | Fund Weighting (%) |
Change from Previous Quarter |
Over/Underweight Relative to Index (%) |
|||||
|---|---|---|---|---|---|---|---|---|
| Financials |
|
0.4 |
|
|||||
| Health Care |
|
0.2 |
|
|||||
| Utilities |
|
2.8 |
|
|||||
| Telecommunication Services |
|
0.9 |
|
|||||
| Consumer Discretionary |
|
1.7 |
|
|||||
| Materials |
|
0.7 |
|
|||||
| Energy |
|
2.3 |
|
|||||
| Consumer Staples |
|
0.9 |
|
|||||
| Industrials |
|
1.2 |
|
|||||
| Information Technology |
|
0.5 |
|
| Strongest Performers | |
| Holding | Contribution (%) |
| Celgene Corp. | 0.7 |
| Community Health Systems, Inc. | 0.6 |
| Incyte Corp. | 0.4 |
| URS Corp. | 0.4 |
| Thermo Fisher Scientific, Inc. | 0.4 |
| Weakest Performers | |
| Holding | Contribution (%) |
| Capital One Financial Corp. | -0.1 |
| EMC Corp. | -0.1 |
| Ashland, Inc. | -0.1 |
| Bank of America Corp. | 0.0 |
| Humana, Inc. | 0.0 |
I WANT TO ...
FUND DOCUMENTS
RELATED CONTENT
| 03/27/2013 | Article |
| 11/27/2012 | Article |
| 11/15/2012 | Article |
| 09/20/2012 | Article |
| 09/07/2012 | Video |
| 07/05/2012 | Article |
| Market Capitalization Breakdown | |
| Giant | 25.7% |
| Large | 44.5% |
| Mid | 26.5% |
| Small | 3.3% |
|
Weighted Average Market Cap. |
59.7 B |
| P/B Ratio | 2.0x |
| P/E Ratio | 16.6x |
|
Portfolio Turnover Ratio (as of 10/31/2011) |
55.1% |
| Number of Holdings | 95 |
| Total Net Assets | $5.11 B |
|
|
Robert P. Fetch, CFA
Partner Years Experience: 37 |
|
Deepak Khanna, CFA
Partner Years Experience: 18 |
|
Sean J. Aurigemma
Years Experience: 21 |
Performance data quoted is historical. Past performance is not indicative of future results. Current performance may be higher or lower than the performance quoted. The investment return and principal value of an investment in the Fund will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than their original cost. To obtain performance data current to the most recent quarter-end, go to quarter ending performance on our Website or call Lord Abbett at (888) 522-2388.
1 The Fund’s dividend yield is shown without sales charges (at NAV) and with maximum sales charges (at MOP). The Fund’s dividend yield takes into account any fee waiver or expense limitation arrangements, if any. Without such fee waivers or expense limitation arrangements, the Fund’s dividend yield would have been lower. Information regarding any fee waivers or expense limitation arrangements applicable to the Fund is provided with the Fund’s expense ratio information.
Index (%)
Russell 3000® Index